- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 Inhibitor
Total 106478 results
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
The Affiliated Hospital of Xuzhou Medical UniversityNot yet recruitingAdvanced Solid TumorChina
-
Buzzard PharmaceuticalsBaylor Research InstituteRecruitingSolid Tumor, AdultUnited States
-
Merck Sharp & Dohme LLCRecruitingCervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditionsCanada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
-
Merck Sharp & Dohme LLCCompleted
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
Memorial Sloan Kettering Cancer CenterXencor, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Hunan Province Tumor HospitalCompleted
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Overall Survival | Progression-free Survival | Clinical Benefit RateChina
-
Changhai HospitalNot yet recruitingHER-2 Protein Overexpression | Esophageal Squamous Carcinoma
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.CompletedCholangiocarcinoma | Biliary Tract CancerChina
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
University of PadovaDepartment of Ophthalmology, Conegliano Hospital, Treviso, ItalyUnknownNeovascular Age-Related Macular DegenerationItaly
-
Gilead SciencesNimbus ApolloCompletedPD Effects of GS-0976 (NDI-010976) on Fractional DNLUnited States
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical UniversityActive, not recruitingBiliary Tract CarcinomaChina
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
University Hospital, LilleINSERM U1189 ONCOTHAIRecruitingMalignant Pleural Mesothelioma | Mesotheliomas PleuralFrance
-
Shi MingSuspended
-
Agenus Inc.Withdrawn
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular CarcinomaChina
-
The First Hospital of Jilin UniversityRecruiting
-
Fujian Cancer HospitalSuzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingEsophageal Neoplasms | Esophageal Squamous Cell CarcinomaChina
-
Merck Sharp & Dohme LLCWithdrawn
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Diwakar DavarMerck Sharp & Dohme LLC; Gateway for Cancer ResearchNot yet recruitingPD-1 Refractory Advanced MelanomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsSpain, Korea, Republic of, China, Taiwan, Turkey, Greece, United States, Croatia, Serbia, Canada, Mexico, Cyprus, Georgia
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
AnaptysBio, Inc.RecruitingRheumatoid ArthritisUnited States, Argentina, Estonia, Georgia, Hungary, Mexico, Moldova, Republic of, Peru, Poland, Slovakia, Belgium, Canada, Germany, Italy, Spain
-
Chinese PLA General HospitalUnknown
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Ruhr University of BochumUnknown
-
Hunan Cancer HospitalRecruitingChemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic DisorderChina
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Merck Sharp & Dohme LLCGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingUterine Cervical NeoplasmsCanada, United States, Australia, Austria, Belgium, Brazil, Chile, China, Colombia, Czechia, France, Germany, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Norway, Peru, Russian Federation, Spain, Sweden, ... and more
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada